0001472827-23-000006.txt : 20230302
0001472827-23-000006.hdr.sgml : 20230302
20230302161308
ACCESSION NUMBER: 0001472827-23-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230302
DATE AS OF CHANGE: 20230302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Solaiman Shereen
CENTRAL INDEX KEY: 0001472827
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 23699068
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
wf-form4_167779157228780.xml
FORM 4
X0306
4
2023-03-01
0
0000899923
MYRIAD GENETICS INC
MYGN
0001472827
Solaiman Shereen
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
Chief People Officer
Common Stock
2023-03-01
4
A
0
15856
0
A
15856
D
Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.
By: Justin Hunter For: Shereen Solaiman
2023-03-02